[Mechanism of p53 gene mutation in the development of urologic cancer].
With DNA polymerase chain reaction-single strand conformation polymorphism assay followed by direct DNA sequencing, p53 gene mutation was examined in bladder transitional epithelial cell carcinoma, renal cell carcinoma and testicular seminoma. p53 gene mutation was found in 7 cases (35%) of bladder carcinoma and 4 cases (23.5%) of testicular seminoma. Inactivation of Rb gene and activation of ras and c-erbB-2 were also studied. The results suggest that development of urologic neoplasms is closely associated with p53 gene mutation and involves loss of expression of Rb and aberrant expression of ras and c-erbB-2.
Ye
D W
DW
Department of Urology, Changhai Hospital, 2nd Military University, Shanghai.
Zheng
J F
JF
Qian
S X
SX
D016161:Genes, Retinoblastoma; D018734:Genes, erbB-2; D016158:Genes, p53; D006801:Humans; D007680:Kidney Neoplasms / Q000235:genetics; D008297:Male; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D013736:Testicular Neoplasms / Q000235:genetics; D001749:Urinary Bladder Neoplasms / Q000235:genetics; D014565:Urogenital Neoplasms / Q000235:genetics*